Pharmagreen Biotech Inc.
PHBI
Pharmagreen Biotech Inc. (the Company ) was incorporated under the laws of the State of Nevada on November 26, 2007. The Company's mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets of high CBD hemp and other flora and offering full spectrum DNA testing for plant identification, li…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$501K
▲ +80.7% YoY
Op. Margin
–
ROIC
58.67%
▼ -19110.4pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$139K
▼ -107.0% YoY
Net Debt
$19K
Cash & Equiv.
$5K
Continue Research
Peers
Airports, Flying Fields & Airport Terminal Services · Pick stocks to compare with PHBI
Pharmagreen Biotech (PHBI) in two numbers
Questions about Pharmagreen Biotech
Does Pharmagreen Biotech (PHBI) pay a dividend?
No. Pharmagreen Biotech (PHBI) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 14 Aug 2023 (period ending 30 Jun 2023), SEC. Price: last close 20 Oct 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in PHBI's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PHBI
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.